查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1533633

3D 生物列印市场规模、份额和成长分析：按组件、按材料、按技术、按地区 - 行业预测，2024-2031 年

3D Bioprinting Market Size, Share, Growth Analysis, By Component (3D Bioprinters, Bioinks), By Material (Living Cell, Hydrogel), By Technology (Inkjet-based, Magnetic Levitation), By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球3D生物列印市场规模将达到10.8亿美元，从2023年的13亿美元成长到2031年的59.2亿美元，预计在预测期间（2024-2031年）成长。 。

器官移植市场的成长动力是器官捐赠者的短缺和患有慢性呼吸道疾病的人口老化。研究和开发投资的增加、技术进步以及慢性病盛行率的上升预计将在预测期内推动市场扩张。 3D 列印由于能够製造用于移植的肾臟、心臟和肺部等复杂器官，因此在医学领域变得越来越重要。与传统的器官移植有被接受者身体排斥的风险不同，3D列印器官使用来自患者自身血液的细胞，降低了排斥的风险。这项技术可以创造新的器官和修復骨折，在医学上具有广阔的前景。此外，3D生物列印能够生产义肢来取代失去的腿，为需要捐赠器官的传统方法提供更快、更有效的替代方案。对器官的高需求和捐赠者数量有限之间的差距导致移植等待时间很长。为了应对这项挑战，科学家们正在努力开发人造器官。然而，目前的人造器官尚不适合人体移植。这种供需之间的差距正在推动3D列印器官的发展，旨在满足器官移植领域未满足的商业性需求。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 贸易分析
  • 专利分析
  • 市场生态系统
  • 客户和购买标准分析
  • 监管环境
  • PESTEL分析
  • 创新矩阵
  • 重点投资分析
  • 关键成功因素
  • 市场魅力指数
  • 竞争程度

3D 生物列印市场：按组成部分

  • 市场概况
  • 3D生物列印机
    • 微挤压生物印表机
    • 喷墨3D生物列印机
    • 雷射辅助生物印表机
    • 基于立体光刻技术的生物印表机
    • 磁性3D生物列印机
    • 其他的
  • 生物墨水
    • 天然生物墨水
    • 混合生物墨水
    • 合成生物墨水
  • 软体
  • 消耗品

3D 生物列印市场：依材料分类

  • 市场概况
  • 活细胞
  • 水凝胶
  • 细胞外基质
  • 其他的

3D 生物列印市场：依应用分类

  • 市场概况
  • 研究用途
    • 药物研究
    • 再生医学
    • 3D细胞培养
  • 临床应用
    • 皮肤
    • 骨/软骨
    • 血管
    • 其他的

3D 生物列印市场：依技术分类

  • 市场概况
  • 磁浮
  • 喷墨底座
  • 注射器底座
  • 雷射基地
  • 其他的

3D 生物列印市场：依最终用户划分

  • 市场概况
  • 学术/研究机构
  • 製药和生物技术公司
  • 医院

3D 生物列印市场规模：按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率（2023年）

主要企业简介

  • Organovo Holdings, Inc.（US）
  • 3D Systems, Inc.（US）
  • CELLINK AB（Sweden）
  • Stratasys Ltd.（US）
  • Rokit Healthcare（Korea）
  • Poietis SAS（France）
  • Aspect Biosystems Ltd.（Canada）
  • Cyfuse Biomedical KK（Japan）
  • Tissuelabs（Switzerland）
  • Advanced Solutions, Inc.（US）
  • RegenHU Ltd.（Switzerland）
  • Materialise NV（Belgium）
  • Microdrop Technologies GmbH（Germany）
  • GeSiM mbH（Germany）
  • 3D Biotek, LLC（US）
  • REGEMAT 3D, SL（Spain）
  • POIETIS（France）
  • SUNP BIOTECH（China）
  • MEDPRIN（China）
  • PRODWAYS（France）
简介目录
Product Code: SQMIG20I2072

Global 3D Bioprinting Market size was valued at USD 1.08 Billion in 2022 and is poised to grow from USD 1.3 Billion in 2023 to USD 5.92 Billion by 2031, growing at a CAGR of 20.8% in the forecast period (2024-2031).

The growth of the organ transplantation market is driven by a shortage of organ donors and an aging population with chronic respiratory diseases. Increased investment in research and development, technological advancements, and the rising prevalence of chronic illnesses are expected to fuel market expansion over the forecast period. 3D printing is gaining significance in the medical field for its ability to produce complex organs such as kidneys, hearts, and lungs for transplants. Unlike traditional organ transplants, which risk rejection by the recipient's body, 3D-printed organs use cells derived from the patient's own blood, reducing the risk of rejection. This technology holds great promise in medicine, allowing for the creation of new organs and the repair of fractured bones. Moreover, 3D bioprinting enables the production of prosthetic limbs to replace lost legs, offering a faster and more efficient alternative compared to traditional methods that require donor organs. The disparity between the high demand for organs and the limited number of donors results in longer waiting times for transplants. To address this challenge, scientists are working on developing synthetic organs. However, current synthetic organs are not yet suitable for human transplantation. This gap between demand and supply is driving the advancement of 3D-printed organs, aiming to meet the unmet commercial needs in the field of organ transplantation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 3D Bioprinting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 3D Bioprinting Market Segmental Analysis

Global 3D bioprinting market is segmented based on Component, Material, Application, Technology, End-user, and Region. Based on Component, the market is segmented into 3D Bioprinters (Micro Extrusion Bioprinters, Inkjet 3d Bioprinters, Laser-assisted Bioprinters, Stereolithography-based Bioprinters, Magnetic 3d Bioprinters, Other), Bioinks (Natural Bioinks, Hybrid Bioinks, Synthetic Bioinks), Software, And Consumables. Based on Material, the market is segmented into liVing Cells, Hydrogels, Extracellular Matrices, And Other. Based on Application, the market is segmented into Research Applications (Drug Research, Regenerative Medicine, 3d Cells Culture), And Clinical Applications (Skin, Bone & Cartilage, Blood Vessels, Other). Based on Technology, the market is segmented into Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, And Others. Based on End-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, And Hospitals. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 3D Bioprinting Market

Pharmaceutical companies are increasingly adopting 3D bioprinting technologies to enhance the discovery and development of new medications. Unlike traditional drug testing methods, 3D bioprinting offers a more cost-effective and safer alternative. This technology significantly accelerates the drug testing process, enabling pharmaceutical firms to evaluate a drug within hours rather than the three to six years typically required for new drug development. By using 3D-printed tissues, research and development teams can conduct early testing and preclinical trials more efficiently. The advantages of 3D bioprinting include reduced reliance on animal testing, improved productivity, and a faster drug development timeline. Additionally, the growing application of 3D printing in the cosmetic industry is contributing to market expansion. Since March 2013, the European Commission has prohibited animal testing for cosmetics. In response, some cosmetics and healthcare companies have turned to 3D bioprinting to create innovative 3D tissue models and develop new drug screening techniques, further driving the growth of this technology.

Restraints in the Global 3D Bioprinting Market

The high cost of equipment and bioinks necessary for producing functional tissues and organs presents a significant challenge for research institutions and medical facilities seeking to adopt and integrate 3D bioprinting technologies. Additionally, the complexity of the procedures and the need for skilled personnel further increase operational costs. These factors limit the widespread adoption and growth of 3D bioprinting. Consequently, the high expenses and technical barriers are restraining the expansion of the 3D bioprinting market.

Market Trends of the Global 3D Bioprinting Market

Burns and scars, especially on visible parts of the body, can significantly affect an individual's appearance. As consumer awareness of personal appearance rises, there is a growing demand for dermal surgeries and treatments worldwide. According to the National Institute on Aging, a substantial portion of individuals aged 16 to 33 is increasingly adopting advanced dermatological solutions. This trend is creating substantial opportunities for manufacturers of related products. The rising focus on self-care is a key driver behind the expansion of the 3D bioprinting market in developed regions. Additionally, 3D bioprinting technology is playing a crucial role in healthcare by facilitating the bioprinting of skin tissues, further contributing to market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Trade Analysis
  • Patent Analysis
  • Ecosystem of the Market
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • PESTEL Analysis
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Market Attractive Index
  • Degree of Competition

3D Bioprinting Market by Component

  • Market Overview
  • 3D Bioprinters
    • Micro Extrusion Bioprinters
    • Inkjet 3D Bioprinters
    • Laser-assisted Bioprinters
    • Stereolithography-based Bioprinters
    • Magnetic 3D Bioprinters
    • Other
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks
  • Software
  • Consumables

3D Bioprinting Market by Material

  • Market Overview
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other

3D Bioprinting Market by Application

  • Market Overview
  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Applications
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other

3D Bioprinting Market by Technology

  • Market Overview
  • Magnetic Levitation
  • Inkjet-based
  • Syringe-based
  • Laser-based
  • Others

3D Bioprinting Market by End User

  • Market Overview
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals

3D Bioprinting Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • Italy
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Organovo Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3D Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CELLINK AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stratasys Ltd. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rokit Healthcare (Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Poietis SAS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspect Biosystems Ltd. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyfuse Biomedical K.K. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tissuelabs (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Solutions, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RegenHU Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Materialise NV (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microdrop Technologies GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeSiM mbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3D Biotek, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • REGEMAT 3D, SL (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • POIETIS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SUNP BIOTECH (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDPRIN (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRODWAYS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments